IMA
Imagene Bio Reports Q2 2026 Financial Results and Appoints New CFO
The biotech company reported $136.2 million in cash and aims for funding into early 2028.
IMA news
Latest 1 stories · newest Aug 5, 2026
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same IMA feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/IMA/newsSTART FREE